TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $65
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Steven Mah maintains a Buy rating on Twist Bioscience (NASDAQ:TWST) and raises the price target from $55 to $65.
June 13, 2024 | 4:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen analyst Steven Mah maintains a Buy rating on Twist Bioscience and raises the price target from $55 to $65.
The raised price target and maintained Buy rating from a reputable analyst are likely to positively impact investor sentiment and drive short-term price appreciation for Twist Bioscience.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100